Management of late arrhythmias in adults with repaired congenital heart disease

被引：0

作者：

Huang J.H. ^{[1
]}

Balaji S. ^{[1
]}

机构：

[1] Doernbecher Children's Hospital, CDRC-P, Portland, OR 97239

来源：

Current Treatment Options in Cardiovascular Medicine | 2013年 / 15卷 / 5期

基金：

美国国家卫生研究院;

关键词：

Adult congenital heart disease; Arrhythmias; Cardiac surgery; Congenital heart disease;

D O I：

10.1007/s11936-013-0254-5

中图分类号：

学科分类号：

摘要：

Opinion statement: As survival of patients with congenital heart disease improves with surgery and the population of patients with repaired adult congenital heart disease (ACHD) age, understanding complications such as arrhythmias has become more important. Arrhythmias account for significant morbidity and mortality in the ACHD population. Atrial arrhythmias occur in 15 % of patients with ACHD and, in patients with severe congenital heart disease (CHD), more than 50 % develop atrial arrhythmias by the age of 65 years [1]. This article aims to give an overview of arrhythmias seen in the ACHD population and the treatment modalities available now. © 2013 Springer Science+Business Media New York.

引用

页码：615 / 631

页数：16

共 44 条

[31]

Stephenson E.A., Casavant D., Tuzi J., Et al., Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease, Am J Cardiol, 92, pp. 871-876, (2003)

[32]

Stulak J.M., Dearani J.A., Puga F.J., Et al., Right-sided Maze procedure for atrial tachyarrhythmias in congenital heart disease, Ann Thorac Surg, 81, pp. 1780-1785, (2006)

[33]

Stulak J.M., Dearani J.A., Burkhart H.M., Et al., The surgical treatment of concomitant atrial arrhythmias during redo cardiac operations, Ann Thorac Surg, 94, pp. 1894-1900, (2012)

[34]

Verheugt C.L., Uiterwaal C., Van Der Velde E.T., Et al., Mortality in adult congenital heart disease, Eur Hear J, 31, pp. 1220-1229, (2010)

[35]

Silka M.J., Bar-Cohen Y., A contemporary assessment of the risk for sudden cardiac death in patients with congenital heart disease, Pediatr Cardiol, 33, pp. 452-460, (2012)

[36]

Russo A.M., Stainback R.F., Bailey S.R., Et al., Heart Rhythm, (2013)

[37]

Khanna A.D., Warnes C.A., Phillips S.D., Et al., Single-center experience with implantable cardioverter-defibrillators in adults with complex congenital heart disease, Am J Cardiol, 108, pp. 729-734, (2011)

[38]

Olde Nordkamp L.R.A., Abkenari L.D., Boersma L.V.A., Et al., The entirely subcutaneous implantable cardioverter-defrillator, J Am Coll Cardiol, 60, 19, pp. 1933-1939, (2012)

[39]

Garson Jr.A., Kanter R.J., Management of the child with Wolff-Parkinson-White syndrome and supraventricular tachycardia: Model for cost-effectiveness, J Cardiovax Electrophysiol, 8, pp. 1320-1326, (1997)

[40]

Gorenek B., Kudaiberdieva G., Cost analysis of radiofrequency catheter ablation for atrial fibrillation, Int J Cardiol, (2013)

← 1 2 3 4 5 →